Download presentation
Published byFrederick Sutton Modified over 9 years ago
1
Epidemiology of Infectious Corneal Ulcers at Tertiary Centers in Vancouver, BC
Karolien Termote, Aaron W Joe, Andrea L Butler, Simon J Holland, Sonia N Yeung None of the authors have a financial interest in the subject matter of this poster.
2
Purpose To study the epidemiology of cultured infectious corneal ulcers in Vancouver, BC, Canada. Which are the most frequent pathogens? What is their sensitivity profile? Which pathogens are associated with contactlens wear?
3
Methods This is a multicenter, retrospective, observational case series and chart review. Predetermined search terms were entered into the hospitals’ electronic microbiology databases to create a cohort of patients that had undergone corneal scrapings for ulcers from April 2006 to March 2011. All specimens were plated on culture media. Cultured species were identified, and antimicrobial sensitivities were performed. Clinical charts were then reviewed to identify associated contactlens wear.
4
Results: demographics
Inclusion of 281 scrapings from 280 patients 140 males; 140 females Average age 56,97 yrs 50,4% right eyes Total Corneal cultures (N) 153 128 281 Positive cultures (N) 115 96 211 Recovery (%) 75,2% 75,0% 75,1% Table 1: Culture Recovery Rate
5
Results: recovered pathogens
N (%) Positive Isolates Gram S. epidermidis / CNS 40 (34.8%) 39 (40.6%) Staph aureus 25 (21.7%) 9 (9.4%) Streptococcus 19 (16.5%) 16 (16.7%) Corynebacterium 13 (11.3%) 8 (8.3%) MRSA 3 (2.6%) 2 (2.1%) Gram Negative Isolates Moraxella 7 (6,1%) 10 (10.4%) Pseudomonas 4 (3,5%) Serratia 5 (5.2%) Haemophilus 1 (0.9%) (4.2%) Fungal Isolates Candida (7.0%) Aspergillus (1.7%) Other (1.0%) Acanthamoeba 6 Table 2: Prevalence of Cultured Microorganisms by Period
6
Table 3: Ratio of Gram Positive / Gram Negative Isolates
Results: Gram Stain Total Gram Positive (N) 115 85 Total Gram Negative (N) 19 33 Ratio (G+:G-) 1:0.16 1:0.39 Table 3: Ratio of Gram Positive / Gram Negative Isolates
7
Results: Mono- vs Polymicrobial
Monomicrobial Isolates (%) 73.0% 72.9% Polymicrobial Isolates (%) 27.0% 27.1% Table 4: Mono-/Polymicrobial Isolates by Period Monomicrobial G+ Isolates (%) 67,2% 49,8% Monomicrobial G- Isolates (%) 15,1% 34,2% Monomicrobial Acanthamoeba (%) 7,1% 5,7% Polymicrobial with G+ (%) 97,0% 96,6% Polymicrobial with G- (%) 15,9% 27,8% Polymicrobial with Acanthamoeba (%) 0% 3,8% Table 5: Etiology of Mono-/Polymicrobial Isolates by Period
8
Results: sensitivity to antibiotics
Table 6: In Vitro Sensitivity to Antibiotics by Period
9
Results: sensitivity to antibiotics
Table 8: In Vitro Sensitivity of Gram Positive Isolates to Antibiotics Table 9: In Vitro Sensitivity of Gram Negative Isolates to Antibiotics
10
Results: sensitivity to antibiotics
CNS Moraxella Ofloxacin 65,4% 100,0% Ciprofloxacin Moxifloxacin 80,8% Gentamicin 84,0% Tobramycin 84,6% Table 10: Sensitivity of Most Prevalent Gram Positive and Gram Negative Species to Empirically Used Antibiotics
11
Results: contactlens association
CL non-CL Gram Positive Isolates % Staph aureus 0,0% 14,0% MRSA 2,3% 1,7% S. epidermidis / CNS 25,6% 28,1% Streptococcus 9,3% 12,8% Corynebacterium 8,3% Total Gram Positive 46,5% 74,8% Gram Negative Isolates % Pesudomonas 2,9% Moraxella 6,6% Serratia 4,7% 1,2% Haemophilus 0,8% Total Gram Negative 20,9% 17,8% Fungal Isolates % Candida 7,0% 4,1% Aspergillus Other Total Fungal 11,6% Acanthamoeba
12
Conclusion Positive culture results were most commonly Gram positive bacteria, followed by Gram negative bacteria, then fungi, and finally parasites. We found an increase in Gram negative isolates over time, both in mono- and polymicrobial ulcers. General sensitivity to moxifloxacin, gentamicin and oxacillin decreased over time. Frequently empirically used antibiotics have poorer coverage for Gram positive isolates than for Gram negative isolates. Contactlens related ulcers were, in comparison to non contactlens related ulcers, more often caused by Gram negative pathogens, fungi and Acanthamoeba species.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.